Concepedia

Thomas A. Werfel

TA

Statistics

Publications

26

Citations

1.6K

H-Index

19

Active since

2013

Affiliations

Vanderbilt University(Current)

University of Mississippi

Vanderbilt University Medical Center

University of Mississippi Medical Center

Vanderbilt Health

Thomas A. Werfel is an author at Vanderbilt University specializing in drug delivery, pharmacy, and nanoparticle drug delivery.

ORCID

Publications per year

2013–2025

26

Publications

26

Cell Protective, ABC Triblock Polymer-Based Thermoresponsive Hydrogels with ROS-Triggered Degradation and Drug Release

Mukesh Kumar Gupta, John R. Martin, Thomas A. Werfel et al. · Journal of the American Chemical Society · 2014 · 261 citations

, , +17

Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers

Martina Miteva, Kellye C. Kirkbride, Kameron V. Kilchrist et al. · Biomaterials · 2014 · 143 citations · Full text

, , +14

Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing

Samantha M. Sarett, Thomas A. Werfel, Linus Lee et al. · Proceedings of the National Academy of Sciences · 2017 · 130 citations · Full text

, , +17

Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol

Meredith A. Jackson, Thomas A. Werfel, Elizabeth J. Curvino et al. · ACS Nano · 2017 · 126 citations · Full text

, , +17

Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability

Kameron V. Kilchrist, Somtochukwu C. Dimobi, Meredith A. Jackson et al. · ACS Nano · 2019 · 118 citations

, , +17

1–5 of 26